Also known as: BK
Bradykinin is a peptide that acts as a pro-inflammatory mediator within the body. It is classified under immunomodulation peptides and plays a crucial role in various physiological processes, particularly in inflammation and pain signaling. Bradykinin is a nonapeptide composed of nine amino acids and is derived from kininogen through the action of the enzyme kallikrein.
Bradykinin is primarily known for its ability to induce vasodilation, increase vascular permeability, and stimulate pain receptors. Its functions are vital in the body’s response to injury and infection, making it a significant focus for research in immunology and related fields.
Bradykinin operates through specific receptors known as B1 and B2 receptors. When released, it binds to these receptors, leading to a cascade of cellular responses that promote inflammation and pain. This binding results in the dilation of blood vessels, allowing for increased blood flow to affected areas, which is essential for the immune response.
The activation of B2 receptors is primarily responsible for the immediate effects of bradykinin, such as vasodilation and increased permeability. In contrast, B1 receptors are typically upregulated during inflammatory states, contributing to prolonged inflammatory responses.
Bradykinin serves as a significant pro-inflammatory mediator, influencing various physiological responses related to inflammation and pain. Its mechanisms and effects make it a critical subject of research in understanding immune modulation and potential therapeutic applications.
Last updated: Feb 25, 2026